Despite limited growth expectations, Jiangxi Synergy Pharmac...

Despite limited growth expectations, Jiangxi Synergy Pharmaceutical's P/E ratio is similar to the market, indicating potential investor oversight. The company's weak earnings outlook and slower growth could risk a share price decline.